Novel Proteoliposome-Based Vaccine against <i>E. coli</i>: A Potential New Tool for the Control of Bovine Mastitis
<i>Escherichia coli</i> is an important causative agent of clinical mastitis in cattle. Current available vaccines have shown limited protection. We evaluated the efficacy of a novel vaccine based on bacterial proteoliposomes derived from an <i>E. coli</i> field strain. Femal...
Main Authors: | John Quiroga, Sonia Vidal, Daniela Siel, Mario Caruffo, Andrea Valdés, Gonzalo Cabrera, Lissette Lapierre, Leonardo Sáenz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Animals |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2615/12/19/2533 |
Similar Items
-
Effectiveness of a proteoliposome-based vaccine against salmonid rickettsial septicaemia in Oncorhynchus mykiss
by: Mario Caruffo, et al.
Published: (2021-08-01) -
The Prevalence of <i>Escherichia coli</i> Derived from Bovine Clinical Mastitis and Distribution of Resistance to Antimicrobials in Part of Jiangsu Province, China
by: Tianle Xu, et al.
Published: (2022-12-01) -
Reconstitution in Proteoliposomes of the Recombinant Human Riboflavin Transporter 2 (SLC52A2) Overexpressed in <i>E. coli</i>
by: Lara Console, et al.
Published: (2019-09-01) -
Over-Production of the Human SLC7A10 in <i>E. coli</i> and Functional Assay in Proteoliposomes
by: Michele Galluccio, et al.
Published: (2023-12-01) -
Anti-Tumor Effects of Bak-Proteoliposomes against Glioblastoma
by: Lavinia Liguori, et al.
Published: (2015-09-01)